Cargando…

Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study

INTRODUCTION: HPTN 071 (PopART) is a three‐arm community randomized trial in Zambia and South Africa evaluating the impact of a combination HIV prevention package, including universal test and treat (UTT), on HIV incidence. This nested study examined factors associated with timely linkage‐to‐care an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabapathy, Kalpana, Mubekapi‐Musadaidzwa, Constance, Mulubwa, Chama, Schaap, Ab, Hoddinott, Graeme, Stangl, Anne, Floyd, Sian, Ayles, Helen, Fidler, Sarah, Hayes, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810326/
https://www.ncbi.nlm.nih.gov/pubmed/29251433
http://dx.doi.org/10.1002/jia2.25037
_version_ 1783299736989597696
author Sabapathy, Kalpana
Mubekapi‐Musadaidzwa, Constance
Mulubwa, Chama
Schaap, Ab
Hoddinott, Graeme
Stangl, Anne
Floyd, Sian
Ayles, Helen
Fidler, Sarah
Hayes, Richard
author_facet Sabapathy, Kalpana
Mubekapi‐Musadaidzwa, Constance
Mulubwa, Chama
Schaap, Ab
Hoddinott, Graeme
Stangl, Anne
Floyd, Sian
Ayles, Helen
Fidler, Sarah
Hayes, Richard
author_sort Sabapathy, Kalpana
collection PubMed
description INTRODUCTION: HPTN 071 (PopART) is a three‐arm community randomized trial in Zambia and South Africa evaluating the impact of a combination HIV prevention package, including universal test and treat (UTT), on HIV incidence. This nested study examined factors associated with timely linkage‐to‐care and ART initiation (TLA) (i.e. within six‐months of referral) in the context of UTT within the intervention communities of the HPTN 071 (PopART) trial. METHODS: Of the 7572 individuals identified as persons living with HIV (PLWH) (and not on antiretroviral treatment (ART)) during the first year of the PopART intervention provided by Community HIV‐care Providers (CHiPs) through door‐to‐door household visits, individuals who achieved TLA (controls) and those who did not (cases), stratified by gender and community, were randomly selected to be re‐contacted for interview. Standardized questionnaires were administered to explore factors potentially associated with TLA, including demographic and behavioural characteristics, and participants’ opinions on HIV and related services. Odds ratios comparing cases and controls were estimated using a multi‐variable logistic regression. RESULTS: Data from 705 participants (333 cases/372 controls) were analysed. There were negligible differences between cases and controls by demographic characteristics including age, marital or socio‐economic position. Prior familiarity with the CHiPs encouraged TLA (aOR of being a case: 0.58, 95% CI: 0.39 to 0.86, p = 0.006). Participants who found clinics overcrowded (aOR: 1.51, 95% CI: 1.08 to 2.12, p = 0.006) or opening hours inconvenient (aOR: 1.63, 95% CI: 1.06 to 2.51, p = 0.02) were less likely to achieve TLA, as were those expressing stronger feelings of shame about having HIV (p (trend) = 0.007). Expressing “not feeling ready” (aOR: 2.75, 95% CI: 1.89 to 4.01, p < 0.001) and preferring to wait until they felt sick (aOR: 2.00, 95% CI: 1.27 to 3.14, p = 0.02) were similarly indicative of being a case. Worrying about being seen in the clinic or about how staff treated patients was not associated with TLA. While the association was not strong, we found that the greater the number of self‐reported lifetime sexual partners the more likely participants were to achieve TLA (p (trend) = 0.06). There was some evidence that participants with HIV‐positive partners on ART were less likely to be cases (aOR: 0.75, 95% CI: 0.53 to 1.06, p = 0.07). DISCUSSION: The lack of socio‐demographic differences between cases and controls is encouraging for a “universal” intervention that seeks to ensure high coverage across whole communities. Making clinics more “patient‐friendly” could enhance treatment uptake further. The finding that those with higher risk behaviour are more actively engaging with UTT holds promise for treatment‐as‐prevention.
format Online
Article
Text
id pubmed-5810326
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58103262018-02-14 Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study Sabapathy, Kalpana Mubekapi‐Musadaidzwa, Constance Mulubwa, Chama Schaap, Ab Hoddinott, Graeme Stangl, Anne Floyd, Sian Ayles, Helen Fidler, Sarah Hayes, Richard J Int AIDS Soc Research Articles INTRODUCTION: HPTN 071 (PopART) is a three‐arm community randomized trial in Zambia and South Africa evaluating the impact of a combination HIV prevention package, including universal test and treat (UTT), on HIV incidence. This nested study examined factors associated with timely linkage‐to‐care and ART initiation (TLA) (i.e. within six‐months of referral) in the context of UTT within the intervention communities of the HPTN 071 (PopART) trial. METHODS: Of the 7572 individuals identified as persons living with HIV (PLWH) (and not on antiretroviral treatment (ART)) during the first year of the PopART intervention provided by Community HIV‐care Providers (CHiPs) through door‐to‐door household visits, individuals who achieved TLA (controls) and those who did not (cases), stratified by gender and community, were randomly selected to be re‐contacted for interview. Standardized questionnaires were administered to explore factors potentially associated with TLA, including demographic and behavioural characteristics, and participants’ opinions on HIV and related services. Odds ratios comparing cases and controls were estimated using a multi‐variable logistic regression. RESULTS: Data from 705 participants (333 cases/372 controls) were analysed. There were negligible differences between cases and controls by demographic characteristics including age, marital or socio‐economic position. Prior familiarity with the CHiPs encouraged TLA (aOR of being a case: 0.58, 95% CI: 0.39 to 0.86, p = 0.006). Participants who found clinics overcrowded (aOR: 1.51, 95% CI: 1.08 to 2.12, p = 0.006) or opening hours inconvenient (aOR: 1.63, 95% CI: 1.06 to 2.51, p = 0.02) were less likely to achieve TLA, as were those expressing stronger feelings of shame about having HIV (p (trend) = 0.007). Expressing “not feeling ready” (aOR: 2.75, 95% CI: 1.89 to 4.01, p < 0.001) and preferring to wait until they felt sick (aOR: 2.00, 95% CI: 1.27 to 3.14, p = 0.02) were similarly indicative of being a case. Worrying about being seen in the clinic or about how staff treated patients was not associated with TLA. While the association was not strong, we found that the greater the number of self‐reported lifetime sexual partners the more likely participants were to achieve TLA (p (trend) = 0.06). There was some evidence that participants with HIV‐positive partners on ART were less likely to be cases (aOR: 0.75, 95% CI: 0.53 to 1.06, p = 0.07). DISCUSSION: The lack of socio‐demographic differences between cases and controls is encouraging for a “universal” intervention that seeks to ensure high coverage across whole communities. Making clinics more “patient‐friendly” could enhance treatment uptake further. The finding that those with higher risk behaviour are more actively engaging with UTT holds promise for treatment‐as‐prevention. John Wiley and Sons Inc. 2017-12-18 /pmc/articles/PMC5810326/ /pubmed/29251433 http://dx.doi.org/10.1002/jia2.25037 Text en © 2017 The Authors. Journal of the International AIDS Society published by John Wiley & sons Ltd on behalf of the International AIDS Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Sabapathy, Kalpana
Mubekapi‐Musadaidzwa, Constance
Mulubwa, Chama
Schaap, Ab
Hoddinott, Graeme
Stangl, Anne
Floyd, Sian
Ayles, Helen
Fidler, Sarah
Hayes, Richard
Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study
title Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study
title_full Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study
title_fullStr Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study
title_full_unstemmed Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study
title_short Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study
title_sort predictors of timely linkage‐to‐art within universal test and treat in the hptn 071 (popart) trial in zambia and south africa: findings from a nested case‐control study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810326/
https://www.ncbi.nlm.nih.gov/pubmed/29251433
http://dx.doi.org/10.1002/jia2.25037
work_keys_str_mv AT sabapathykalpana predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT mubekapimusadaidzwaconstance predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT mulubwachama predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT schaapab predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT hoddinottgraeme predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT stanglanne predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT floydsian predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT ayleshelen predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT fidlersarah predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT hayesrichard predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy
AT predictorsoftimelylinkagetoartwithinuniversaltestandtreatinthehptn071poparttrialinzambiaandsouthafricafindingsfromanestedcasecontrolstudy